Clinical Trials Logo

Filter by:
NCT ID: NCT01058174 Completed - Clinical trials for Liver Transplantation

Liver Transplant European Study Into the Prevention of Fungal Infection

TENPIN
Start date: December 15, 2009
Phase: Phase 3
Study type: Interventional

Prevention of invasive fungal infection in high risk patients following liver transplant.

NCT ID: NCT01058070 Completed - Clinical trials for Gastroesophageal Reflux Disease

An Observational Clinical Feasibility Study of the Magnetic Esophageal Sphincter

Start date: February 2007
Phase: N/A
Study type: Interventional

Magnetic Esophageal Sphincter implant is intended to reinforce Esophageal Sphincter function in the treatment of Gastroesophageal Reflux Disease (GERD)

NCT ID: NCT01057992 Completed - Clinical trials for Gastroesophageal Reflux Disease

A Prospective Evaluation of the Torax Medical Inc. Magnetic Esophageal Sphincter

Start date: March 2007
Phase: Phase 1/Phase 2
Study type: Interventional

A medical device to augment weak lower esophageal sphincter function.

NCT ID: NCT01057810 Completed - Prostate Cancer Clinical Trials

Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer

Start date: May 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if patients with metastatic prostate cancer who have not received chemotherapy live longer when treated with ipilimumab than those treated with a placebo

NCT ID: NCT01057589 Completed - Clinical trials for Head and Neck Neoplasms

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Start date: February 2010
Phase: Phase 2
Study type: Interventional

The purpose of this trial is to estimate progression free survival in patients with recurrent or metastatic head and neck cancer that have not received chemotherapy in this setting.

NCT ID: NCT01056341 Completed - Clinical trials for Infantile Hemangioma

Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy

Start date: January 2010
Phase: Phase 2/Phase 3
Study type: Interventional

There is an unsatisfied medical need for a first-line treatment of proliferating IHs with a good benefit/risk profile. Based on the recent findings of encouraging results obtained with propranolol in a series of infants with severe Infantile Hemangioma (IH), propranolol is expected to be of significant benefit in the management of the condition. The present study has been designed to confirm efficacy of propranolol in severe IH by demonstrating superiority over placebo and to document the safety profile of propranolol in this indication.

NCT ID: NCT01055379 Completed - Parkinson's Disease Clinical Trials

Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn

ACCORDO
Start date: March 2010
Phase: Phase 4
Study type: Interventional

The primary endpoint for this study is the clinical response after 12 weeks of treatment, defined as a change in total score from baseline depressive symptoms as measured by the Beck Depression Inventory-Amended (BDI-IA) total score.

NCT ID: NCT01053715 Completed - Hemophilia A Clinical Trials

Quality of Life Study of Helixate NexGen

Start date: January 2010
Phase: N/A
Study type: Observational

The aim of this study is to describe Health Related Quality of Life (HRQoL) in adolescents and adults with Hemophilia A treated prophylactically or on-demand with Helixate NexGen. The study will also assess the kinds of determinants, including key transitional life events, that might impact HRQoL in this patient population.

NCT ID: NCT01053416 Completed - Clinical trials for Pigment Dispersion Syndrome

Pigment Dispersion Syndrome: Natural History and Possible Protective Effect of a YAG Laser Iridotomy

Start date: January 1993
Phase: N/A
Study type: Interventional

STUDY AIMS 1. To determine the 10-year conversion rate from pigment dispersion syndrome (PDS) to pigmentary glaucoma (PG) 2. To evaluate the possible protective effect of a Yag-laser iridotomy

NCT ID: NCT01053065 Completed - Clinical trials for Hypercholesterolemia

The Multicenter Atorvastatin Plaque Stabilization (MAPS) Study

MAPS
Start date: n/a
Phase: N/A
Study type: Interventional

The impact on cardiovascular events achieved by statin therapy seems to be mostly attributable to the cholesterol-lowering effect with a highly debated contribution of the lipid-independent pleiotropic effects. However, a short-term benefit has been documented for patients treated with statins in acute coronary syndromes and other clinical settings. These observations strengthened the hypothesis of additional, so-called pleiotropic actions of statins. The investigators therefore sought to investigate how different lipid-lowering strategies (non-statin therapy, low-dose statin and high-dose statin) affects cellular composition of carotid plaque over a short-term period of three months. Specifically the investigators tried and dissect the LDL-C lowering impact on plaque cellular composition as compared to the lipid-independent contribution on plaque macrophage and smooth muscle cells.